Form 8-K - Current report:
SEC Accession No. 0001104659-25-055286
Filing Date
2025-06-02
Accepted
2025-06-02 09:40:22
Documents
13
Period of Report
2025-06-02
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2516844d1_8k.htm   iXBRL 8-K 28943
2 EXHIBIT 99.1 tm2516844d1_ex99-1.htm EX-99.1 15760
  Complete submission text file 0001104659-25-055286.txt   217819

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vstm-20250602.xsd EX-101.SCH 3014
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vstm-20250602_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vstm-20250602_pre.xml EX-101.PRE 22358
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2516844d1_8k_htm.xml XML 3675
Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Filer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35403 | Film No.: 251013331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)